PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1538660

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1538660

Global Mucosal Atomization Device Market Size study, by Product Type, by Technology, by End User and Regional Forecasts 2022-2032

PUBLISHED: August 20, 2024

PAGES: 285 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Mucosal Atomization Device Market is valued approximately at USD 712.3 million in 2023 and is anticipated to grow with a healthy growth rate of more than 7.44% over the forecast period 2024-2032. Mucosal Atomization Device (MAD) is a medical tool designed for the administration of medications directly to the mucous membranes, such as those in the nasal or oral cavities. It converts liquid medication into a fine mist, allowing for rapid absorption and fast onset of action. This method is non-invasive, user-friendly, and enhances patient comfort compared to traditional routes such as injections. MADs are commonly used in emergency settings, pain management, and for administering vaccines or sedatives, providing an efficient and effective alternative for drug delivery.

The Global Mucosal Atomization Device Market growth is driven by several key factors, including the rising prevalence of respiratory illnesses, expanding adoption of intranasal drug delivery systems, and surging demand for safer medication delivery solutions. The ability of mucosal atomization devices to provide precise drug delivery enhances their appeal in various medical scenarios. Moreover, rising investments in pharmaceutical AI startups and growing demand for efficient drug development are anticipated to create lucrative opportunities for the market. However, the market faces challenges such as stringent regulatory approval procedures and limited compatibility with different types of medications.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America region is projected to maintain its dominance in the global mucosal atomization device market due to the presence of advanced healthcare facilities, growing demand for non-invasive drug delivery solutions, increasing incidence of respiratory illnesses, and a growing focus on patient-centric models to enhance ease and comfort for patients. Moreover, the presence of key players such as Teleflex Inc., Becton, Dickinson & Company, and Cook Medical, Inc. among others in the region, who are focusing on introducing new and innovative products to gain a competitive edge, is also contributing to the significant growth of the region in the market. Furthermore, the Asia Pacific mucosal atomization device market is anticipated to witness lucrative growth owing to the increasing prevalence of respiratory illnesses, availability of low-cost mucosal atomization devices, and growing awareness towards safe and precision drug delivery options.

Major market players included in this report are:

Becton, Dickinson, and Co.
BTME Group Ltd. (Medtree)
BVM Meditech Pvt. Ltd.
Cook Medical, Inc.
DeVilbiss Healthcare LLC
Intersurgical Ltd.
Kurve Therapeutics
Life-Assist Inc.
Medica Holdings, LLC
Medspray
Pulmodyne, Inc.
Teleflex Inc.

The detailed segments and sub-segment of the market are explained below:

By Product Type:

Nasal Atomization Devices
Fiber Optic Atomization Devices
Laryngo Tracheal Atomization Devices
Bottle Atomizers

By Technology:

Gas Propelled Atomization Devices
Electrical Atomization Devices

By End User:

Hospitals
Ambulatory Surgery Centers
Specialty Clinics

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Mucosal Atomization Device Market Executive Summary

1.1. Global Mucosal Atomization Device Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product Type
- 1.3.2. By Technology
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Mucosal Atomization Device Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Mucosal Atomization Device Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising prevalence of respiratory illnesses
- 3.1.2. Expanding adoption of intranasal drug delivery systems
- 3.1.3. Surging demand for safer medication delivery solutions
3.2. Market Challenges
- 3.2.1. Stringent regulatory approval procedures
- 3.2.2. Limited compatibility with different types of medications
3.3. Market Opportunities
- 3.3.1. Increasing investments in pharmaceutical AI startups
- 3.3.2. Growing demand for efficient drug development
- 3.3.3. Advancements in AI technologies

Chapter 4. Global Mucosal Atomization Device Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Mucosal Atomization Device Market Size & Forecasts by Product Type 2022-2032

5.1. Segment Dashboard
5.2. Global Mucosal Atomization Device Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Nasal Atomization Devices
- 5.2.2. Fiber Optic Atomization Devices
- 5.2.3. Laryngo Tracheal Atomization Devices
- 5.2.4. Bottle Atomizers

Chapter 6. Global Mucosal Atomization Device Market Size & Forecasts by Technology 2022-2032

6.1. Segment Dashboard
6.2. Global Mucosal Atomization Device Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Gas Propelled Atomization Devices
- 6.2.2. Electrical Atomization Devices

Chapter 7. Global Mucosal Atomization Device Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Global Mucosal Atomization Device Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Hospitals
- 7.2.2. Ambulatory Surgery Centers
- 7.2.3. Specialty Clinics

Chapter 8. Global Mucosal Atomization Device Market Size & Forecasts by Region 2022-2032

8.1. North America Mucosal Atomization Device Market
- 8.1.1. U.S. Mucosal Atomization Device Market
  - 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End User breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Mucosal Atomization Device Market
  - 8.1.2.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.1.2.2. Technology breakdown size & forecasts, 2022-2032
  - 8.1.2.3. End User breakdown size & forecasts, 2022-2032
8.2. Europe Mucosal Atomization Device Market
- 8.2.1. UK Mucosal Atomization Device Market
  - 8.2.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.2.1.2. Technology breakdown size & forecasts, 2022-2032
  - 8.2.1.3. End User breakdown size & forecasts, 2022-2032
- 8.2.2. Germany Mucosal Atomization Device Market
  - 8.2.2.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.2.2.2. Technology breakdown size & forecasts, 2022-2032
  - 8.2.2.3. End User breakdown size & forecasts, 2022-2032
- 8.2.3. France Mucosal Atomization Device Market
  - 8.2.3.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.2.3.2. Technology breakdown size & forecasts, 2022-2032
  - 8.2.3.3. End User breakdown size & forecasts, 2022-2032
- 8.2.4. Spain Mucosal Atomization Device Market
  - 8.2.4.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.2.4.2. Technology breakdown size & forecasts, 2022-2032
  - 8.2.4.3. End User breakdown size & forecasts, 2022-2032
- 8.2.5. Italy Mucosal Atomization Device Market
  - 8.2.5.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.2.5.2. Technology breakdown size & forecasts, 2022-2032
  - 8.2.5.3. End User breakdown size & forecasts, 2022-2032
- 8.2.6. Rest of Europe Mucosal Atomization Device Market
  - 8.2.6.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.2.6.2. Technology breakdown size & forecasts, 2022-2032
  - 8.2.6.3. End User breakdown size & forecasts, 2022-2032
8.3. Asia-Pacific Mucosal Atomization Device Market
- 8.3.1. China Mucosal Atomization Device Market
  - 8.3.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.3.1.2. Technology breakdown size & forecasts, 2022-2032
  - 8.3.1.3. End User breakdown size & forecasts, 2022-2032
- 8.3.2. India Mucosal Atomization Device Market
  - 8.3.2.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.3.2.2. Technology breakdown size & forecasts, 2022-2032
  - 8.3.2.3. End User breakdown size & forecasts, 2022-2032
- 8.3.3. Japan Mucosal Atomization Device Market
  - 8.3.3.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.3.3.2. Technology breakdown size & forecasts, 2022-2032
  - 8.3.3.3. End User breakdown size & forecasts, 2022-2032
- 8.3.4. Australia Mucosal Atomization Device Market
  - 8.3.4.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.3.4.2. Technology breakdown size & forecasts, 2022-2032
  - 8.3.4.3. End User breakdown size & forecasts, 2022-2032
- 8.3.5. South Korea Mucosal Atomization Device Market
  - 8.3.5.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.3.5.2. Technology breakdown size & forecasts, 2022-2032
  - 8.3.5.3. End User breakdown size & forecasts, 2022-2032
- 8.3.6. Rest of Asia Pacific Mucosal Atomization Device Market
  - 8.3.6.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.3.6.2. Technology breakdown size & forecasts, 2022-2032
  - 8.3.6.3. End User breakdown size & forecasts, 2022-2032
8.4. Latin America Mucosal Atomization Device Market
- 8.4.1. Brazil Mucosal Atomization Device Market
  - 8.4.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.4.1.2. Technology breakdown size & forecasts, 2022-2032
  - 8.4.1.3. End User breakdown size & forecasts, 2022-2032
- 8.4.2. Mexico Mucosal Atomization Device Market
  - 8.4.2.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.4.2.2. Technology breakdown size & forecasts, 2022-2032
  - 8.4.2.3. End User breakdown size & forecasts, 2022-2032
- 8.4.3. Rest of Latin America Mucosal Atomization Device Market
  - 8.4.3.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.4.3.2. Technology breakdown size & forecasts, 2022-2032
  - 8.4.3.3. End User breakdown size & forecasts, 2022-2032
8.5. Middle East & Africa Mucosal Atomization Device Market
- 8.5.1. Saudi Arabia Mucosal Atomization Device Market
  - 8.5.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.5.1.2. Technology breakdown size & forecasts, 2022-2032
  - 8.5.1.3. End User breakdown size & forecasts, 2022-2032
- 8.5.2. South Africa Mucosal Atomization Device Market
  - 8.5.2.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.5.2.2. Technology breakdown size & forecasts, 2022-2032
  - 8.5.2.3. End User breakdown size & forecasts, 2022-2032
- 8.5.3. Rest of Middle East & Africa Mucosal Atomization Device Market
  - 8.5.3.1. Product Type breakdown size & forecasts, 2022-2032
  - 8.5.3.2. Technology breakdown size & forecasts, 2022-2032
  - 8.5.3.3. End User breakdown size & forecasts, 2022-2032

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Becton, Dickinson, and Co.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. BTME Group Ltd. (Medtree)
- 9.3.3. BVM Meditech Pvt. Ltd.
- 9.3.4. Cook Medical, Inc.
- 9.3.5. DeVilbiss Healthcare LLC
- 9.3.6. Intersurgical Ltd.
- 9.3.7. Kurve Therapeutics
- 9.3.8. Life-Assist Inc.
- 9.3.9. Medica Holdings, LLC
- 9.3.10. Medspray
- 9.3.11. Pulmodyne, Inc.
- 9.3.12. Teleflex Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ